Relationship between protein biomarkers of chemotherapy response and microsatellite status, tumor mutational burden and PD‐L1 expression in cancer patients

Chemotherapy and checkpoint inhibitor immunotherapies are increasingly used in combinations. We determined associations between the presence of anti‐PD‐1/PD‐L1 therapeutic biomarkers and protein markers of potential chemotherapy response. Data were extracted from a clinical‐grade testing database (C...

Descripción completa

Detalles Bibliográficos
Autores principales: Nikanjam, Mina, Arguello, David, Gatalica, Zoran, Swensen, Jeff, Barkauskas, Donald A., Kurzrock, Razelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Cancer Therapy and Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051881/
https://www.ncbi.nlm.nih.gov/pubmed/31479512
http://dx.doi.org/10.1002/ijc.32661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051881/
https://www.ncbi.nlm.nih.gov/pubmed/31479512
http://dx.doi.org/10.1002/ijc.32661

Ejemplares similares